Aligos Therapeutics
Clinical trials sponsored by Aligos Therapeutics, explained in plain language.
-
First human test for hepatitis b drug in kidney patients
Disease control Recruiting nowThis early-stage study is testing a new drug called pevifoscorvir sodium for chronic hepatitis B. It aims to see how the drug is processed by the body and if it is safe for people with varying levels of kidney function. The study will enroll about 30 adults, comparing those with …
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New pill challenges standard hepatitis b treatment in major trial
Disease control Recruiting nowThis study is testing if a new daily pill, ALG-000184, is better than the standard drug tenofovir at controlling the Hepatitis B virus. It will involve about 200 adults with chronic Hepatitis B who are not currently on treatment. Participants will take one of the two pills for 48…
Phase: PHASE2 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Early safety check for hepatitis b drug in people with liver problems
Knowledge-focused Recruiting nowThis early-stage study aims to understand how a new hepatitis B drug is processed in people with moderate liver impairment compared to those with normal liver function. It involves 16 participants who will receive a single dose of the drug. The main goal is to measure drug levels…
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC